Chronic inflammation and lung fibrosis: Pleotropic syndromes but limited distinct phenotypes

Mucosal Immunology

Volumn 5, Issue 5, 2012, Pages 480-484

  Gifford, A H ^a   Matsuoka, M ^a   Ghoda, L Y ^b,c   Homer, R J ^d,e   Enelow, R I ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c Keren Pharmaceuticals   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 13; PRECIPITIN; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC PNEUMONITIS; CHRONIC INFLAMMATION; CIGARETTE SMOKING; CLINICAL FEATURE; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RHEUMATOID ARTHRITIS; TH1 CELL; TH2 CELL; WOUND HEALING;

EID: 84865387232     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.68     Document Type: Review

References (62)

1. Costabel, U., Bonella, F. & Guzman, J. Chronic hypersensitivity pneumonitis. Clin. Chest Med. 33, 151-163 (2012
2. Selman, M. et al. Gene expression profi les distinguish idiopathic pulmonary fi brosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 173, 188-198 (2006
3. Lockstone, H. E. et al. Gene set analysis of lung samples provides insight into pathogenesis of progressive, fi brotic pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 181, 1367-1375 (2010
4. Salvaggio, J. E. & Robert, A. Cooke memorial lecture. Hypersensitivity pneumonitis. J. Allergy Clin. Immunol. 79, 558-571 (1987
5. Ye, Q., Nakamura, S., Sarria, R., Costabel, U. & Guzman, J. Interleukin 12, interleukin 18, and tumor necrosis factor alpha release by alveolar macrophages: Acute and chronic hypersensitivity pneumonitis. Ann. Allergy Asthma Immunol. 102, 149-154 (2009
6. Mroz, R. M., Korniluk, M., Stasiak-Barmuta, A. & Chyczewska, E. Upregulation of Th1 cytokine profi le in bronchoalveolar lavage fl uid of patients with hypersensitivity pneumonitis. J. Physiol. Pharmacol. 59 (Suppl 6), 499-505 (2008
7. Mitaka, K. et al. Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis. Int. Arch. Allergy Immunol. 154, 264-274 (2011
8. Wynn, T. A. Integrating mechanisms of pulmonary fi brosis. J. Exp. Med. 208, 1339-1350 (2011
9. Lee, C. G. et al. Interleukin-13 induces tissue fi brosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809-821 (2001
10. Garcia, C. K. Idiopathic pulmonary fi brosis: update on genetic discoveries. Proc. Am. Thorac. Soc. 8, 158-162 (2011
11. Kaminski, N. & Rosas, I. O. Gene expression profi ling as a window into idiopathic pulmonary fi brosis pathogenesis: can we identify the right target genes? Proc. Am. Thorac. Soc. 3, 339-344 (2006
12. Selman, M., Pardo, A. & Kaminski, N. Idiopathic pulmonary fi brosis: Aberrant recapitulation of developmental programs? PLoS Med. 5, e62 (2008
13. Leslie, K. O. Idiopathic pulmonary fi brosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: A unifying hypothesis regarding etiology and pathogenesis. Arch. Pathol. Lab. Med. 136, 591-600 (2012
14. Rozin, G. F., Gomes, M. M., Parra, E. R., Kairalla, R. A., de Carvalho, C. R. & Capelozzi, V. L. Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology 46, 413-421 (2005
15. Schneider, D. J. et al. Cadherin-11 contributes to pulmonary fi brosis: potential role in TGF-beta production and epithelial to mesenchymal transition. FASEB J. 26, 503-512 (2012
16. Hiwatari, N., Shimura, S., Yamauchi, K., Nara, M., Hida, W. & Shirato, K. Signifi cance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fl uids from idiopathic pulmonary fi brosis patients. Tohoku J. Exp. Med. 181, 285-295 (1997
17. Garcia-Sanchez, O., Lopez-Hernandez, F. J. & Lopez-Novoa, J. M. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int. 77, 950-955 (2010
18. Lomas, N. J., Watts, K. L., Akram, K. M., Forsyth, N. R. & Spiteri, M. A. Idiopathic pulmonary fi brosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers. Int. J. Clin. Exp. Pathol. 5, 58-71 (2012
19. Khalil, N. et al. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fi brosis. Thorax 56, 907-915 (2001
20. Khalil, N., O'Connor, R., Gold, L. I., Parekh, T. & Raghu, G. Biological effects of transforming growth factor-beta(1) in idiopathic pulmonary fi brosis may be regulated by the activation of latent transforming growth factor-beta(1) and the differential expression of transforming growth factor-beta receptors. Chest 120 (1 Suppl), 48S (2001
21. Coward, W. R., Saini, G. & Jenkins, G. The pathogenesis of idiopathic pulmonary fi brosis. Ther. Adv. Respir. Dis. 4, 367-388 (2010
22. Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T. & Zhang, Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56 (2005
23. Pozharskaya, V. et al. Twist: A regulator of epithelial-mesenchymal transition in lung fi brosis. PLoS One 4, e7559 (2009
24. Bridges, R. S., Kass, D., Loh, K., Glackin, C., Borczuk, A. C. & Greenberg, S. Gene expression profi ling of pulmonary fi brosis identifi es Twist1 as an antiapoptotic molecular " rectifi er " of growth factor signaling. Am. J. Pathol. 175, 2351-2361 (2009
25. Morbini, P., Inghilleri, S., Campo, I., Oggionni, T., Zorzetto, M. & Luisetti, M. Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fi brosis. Pathol. Res. Pract. 207, 559-567 (2011
26. Rock, J. R. et al. Multiple stromal populations contribute to pulmonary fi brosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA 108, E1475-E1483 (2011
27. Pham, C. G. et al. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol. Cell. Biol. 27, 3920-3935 (2007
28. Andersson-Sjoland, A., Nihlberg, K., Eriksson, L., Bjermer, L. & Westergren-Thorsson, G. Fibrocytes and the tissue niche i lung repair. Respir. Res. 12, 76 (2011
29. Antoniou, K. M. et al. Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Respir. Med. 104, 1535-1542 (2010
30. Cakouros, D., Raices, R. M., Gronthos, S. & Glackin, C. A. Twist-ing cell fate: mechanistic insights into the role of twist in lineage specifi cation/differentiation and tumorigenesis. J. Cell. Biochem. 110, 1288-1298 (2010
31. Isenmann, S. et al. TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27, 2457-2468 (2009
32. Helmick, C. G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15-25 (2008
33. Englund, M., Joud, A., Geborek, P., Felson, D. T., Jacobsson, L. T. & Petersson, I. F. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology (Oxford, England) 49, 1563-1569 (2010
34. Scublinsky, D. et al. The prevalence of rheumatoid arthritis in Argentina: A capture-recapture study in a city of Buenos Aires province. J. Clin. Rheumatol. 16, 317-321 (2010
35. Anagnostopoulos, I. et al. The prevalence of rheumatic diseases in central Greece: A population survey. BMC Musculoskelet. Disord. 11, 98 (2010
36. Gochuico, B. R. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch. Intern. Med. 168, 159-166 (2008
37. Kanat, F., Levendoglu, F. & Teke, T. Radiological and functional assessment of pulmonary involvement in the rheumatoid arthritis patients. Rheumatol. Int. 27, 459-466 (2007
38. Mohd Noor, N., Mohd Shahrir, M. S., Shahid, M. S., Abdul Manap, R., Shahizon Azura, A. M. & Azhar Shah, S. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int. J. Rheum. Dis. 12, 136-144 (2009
39. Mori, S., Cho, I., Koga, Y. & Sugimoto, M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J. Rheumatol. 35, 1513-1521 (2008
40. Bongartz, T. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum. 62, 1583-1591 (2010
41. Lee, H. K. et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127, 2019-2027 (2005
42. Tsuchiya, Y. et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur. Respir. J. 37, 1411-1417 (2011
43. Kode, A., Yang, S. R. & Rahman, I. Differential effects of cigarette smoke on oxidative stress and proinfl ammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir. Res. 7, 132 (2006
44. Fang, K. C. Mesenchymal regulation of alveolar repair in pulmonary fi brosis. Am. J. Respir. Cell. Mol. Biol. 23, 142-145 (2000
45. Bhandari, V., Maulik, N. & Kresch, M. Hyperoxia causes an increase in antioxidant enzyme activity in adult and fetal rat type II pneumocytes. Lung 178, 53-60 (2000
46. Barbas-Filho, J. V., Ferreira, M. A., Sesso, A., Kairalla, R. A., Carvalho, C. R. & Capelozzi, V. L. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fi brosis (IFP)/usual interstitial pneumonia (UIP). J. Clin. Pathol. 54, 132-138 (2001
47. Kosmider, B., Messier, E. M., Chu, H. W. & Mason, R. J. Human alveolar epithelial cell injury induced by cigarette smoke. PLoS One 6, e26059 (2011
48. Kumar, P. A. et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 infl uenza infection. Cell 147, 525-538 (2011
49. Raghu, G. et al. An offi cial ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fi brosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788-824 (2011
50. Lepperdinger, G. Infl ammation and mesenchymal stem cell aging. Curr. Opin. Immunol. 23, 518-524 (2011
51. Vece, T. J. et al. Rapid and progressive pulmonary fi brosis in 2 families with DNA repair defi ciencies of undetermined etiology. J. Pediatr. 160, 700-702 e3 (2012
52. Diaz de Leon, A. et al. Telomere lengths, pulmonary fi brosis and telomerase (TERT) mutations. PLoS One 5, e10680 (2010
53. Moore, B. B. & Hogaboam, C. M. Murine models of pulmonary fi brosis. Am. J. Physiol. Lung. Cell. Mol. Physiol. 294, L152-L160 (2008
54. Homer, R. J., Elias, J. A., Lee, C. G. & Herzog, E. Modern concepts on the role of infl ammation in pulmonary fi brosis. Arch. Pathol. Lab. Med. 135, 780-788 (2011
55. Murray, L. A. et al. TGF-beta driven lung fi brosis is macrophage dependent and blocked by Serum amyloid P. Int. J. Biochem. Cell Biol. 43, 154-162 (2011
56. Wynn, T. A. Cellular and molecular mechanisms of fi brosis. J. Pathol. 214, 199-210 (2008
57. Lee, C. G. et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fi brosis. J. Exp. Med. 200, 377-389 (2004
58. Munger, J. S. et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary infl ammation and fi brosis. Cell 96, 319-328 (1999
59. Kaminski, N. et al. Global analysis of gene expression in pulmonary fi brosis reveals distinct programs regulating lung infl ammation and fi brosis. Proc. Natl. Acad. Sci. USA 97, 1778-1783 (2000
60. Keith, R. C. et al. A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice. Exp. Lung Res. 38, 55-66 (2012
61. Wakasa-Morimoto, C. et al. Arthritis and pneumonitis produced by the same T cell clones from mice with spontaneous autoimmune arthritis. Int. Immunol. 20, 1331-1342 (2008
62. Vuga, L. J. et al. WNT5A is a regulator of fi broblast proliferation and resistance to apoptosis. Am. J. Respir. Cell Mol. Biol. 41, 583-589 (2009)